Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Version 113 (2025-05-22) was added to the Record History. This is a routine update to the page's history and does not change the study data or status.
    Difference
    0.0%
    Check dated 2025-11-03T00:58:10.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    7%
    Check dated 2025-10-05T08:56:44.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.1.0, indicating a new release with potential changes behind the scenes but no other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:04:04.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing the previous v3.0.1. The 'Back to Top' element was removed as part of the update.
    Difference
    0.4%
    Check dated 2025-09-13T16:52:30.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.4%
    Check dated 2025-09-06T14:30:29.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, enhancing the core content related to the study. Additionally, several sections related to study status and details have been added, which may provide more comprehensive information for users.
    Difference
    100%
    Check dated 2025-08-30T11:18:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.